13F-HR filed by Corriente Advisors, LLC
Corriente Advisors, LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 15 holding rows worth $185,402,000.
- Accession
- 0001085146-21-002500
- Filer
- CIK 1406718
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 15 entries on the cover page, a total value of $185,402,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $185,402,000 with VALUE read as thousands by filing date, 13F file number 028-12875. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MAXAR TECHNOLOGIES INC | 57778K105 | COM | 1,920,333 | $76,660,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 1,486,986 | $17,323,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 449,879 | $17,284,000 | thousands by filing date | |
| COINBASE GLOBAL INC COM CL A | 19260Q107 | Stock | 40,000 | $10,132,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 71,115 | $10,065,000 | thousands by filing date | |
| QUANTUMSCAPE CORP COM CL A | 74767V109 | Stock | 337,316 | $9,870,000 | thousands by filing date | |
| LANTERN PHARMA INC | 51654W101 | COM | 656,364 | $9,583,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 1,383,500 | $9,200,000 | thousands by filing date | |
| KRATOS DEFENSE & SEC SOLUTIO | 50077B207 | COM NEW | 275,738 | $7,856,000 | thousands by filing date | |
| MP MATERIALS CORP | 553368101 | COM CL A | 110,000 | $4,055,000 | thousands by filing date | |
| HIMAX TECHNOLOGIES INC SPONSORED ADR | 43289P106 | ADR | 200,000 | $3,332,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 20,000 | $3,238,000 | thousands by filing date | |
| IRIDIUM COMMUNICATIONS INC | 46269C102 | COM | 80,000 | $3,199,000 | thousands by filing date | |
| ROBLOX CORP CL A | 771049103 | Stock | 30,000 | $2,699,000 | thousands by filing date | |
| DIAMEDICA THERAPEUTICS INC | 25253X207 | COMMON STOCK | 203,641 | $906,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-21-002500 | this filing | 2021-08-16 | acceptance time not in the bulk data set |